Pulse Explorar nav.journalClub Debates Tendências Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

Ognjen Sekulović | Synapse

OS

Ognjen Sekulović

Clostridium difficile and Clostridium perfringens research

Pfizer (United States)

About

Research focus

Clostridium difficile and Clostridium perfringens research

Impact

22 pubs · 1,436 cites · h-index 13

Affiliations

Work Experience

Pfizer (United States)

2024 - 2024

Tufts University

2017 - 2022

Université de Sherbrooke

2011 - 2021

Université des Sciences de la Santé

2013 - 2013

Publications